Moleculin Overview

  • Founded
  • 2006
Founded
  • Status
  • Public
  • Employees
  • 15
Employees
  • Stock Symbol
  • MBRX
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $3.92
  • (As of Monday Closing)

Moleculin General Information

Description

Moleculin Biotech Inc is a clinical-stage pharmaceutical company with its focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
NAS
Primary Office
  • 5300 Memorial Drive
  • Suite 950
  • Houston, TX 77007
  • United States
+1 (713) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Moleculin Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.92 $3.86 $3.12 - $9.30 $110M 28.4M 1.16M -$1.78

Moleculin Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 101,157 37,300 26,840 19,615
Revenue 0 0 0 0
EBITDA (20,460) (17,168) (13,248) (11,812)
Net Income (20,591) (17,355) (13,205) (11,876)
Total Assets 99,784 29,031 25,235 19,585
Total Debt 249 277 379 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Moleculin Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Moleculin‘s full profile, request access.

Request a free trial

Moleculin Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Moleculin Biotech Inc is a clinical-stage pharmaceutical company with its focus on the treatment of highly resistant can
Pharmaceuticals
Houston, TX
15 As of 2020
000.00
000000000 000.00

00000000

ur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mi
0000000000000
000.00
000000&0

00000000

et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut
0000 000000000
Houston, TX
00 As of 0000
00000
000000000 - 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Moleculin Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Potentia Pharmaceuticals Corporate Backed or Acquired 000.00 000000&0
00000000 000000000 Formerly VC-backed Houston, TX 00 00000 000000000 - 00000
000000 Formerly VC-backed Waltham, MA 00 00000 000000000 00000
0000000 0000000000 Corporation The Woodlands, TX 00 00000 000000000 00000
000000 00000000 Venture Capital-Backed Vancouver, Canada 00 000.00 000000 - 000 000.00
You’re viewing 5 of 12 competitors. Get the full list »

Moleculin Executive Team (8)

Name Title Board Seat Contact Info
Walter Klemp Chief Executive Officer & Chairman
Jonathan Foster Executive Vice President & Chief Financial Officer
Donald Picker Ph.D Chief Scientific Officer
Robert Shepard Chief Medical Officer
Sandra Silberman Ph.D Executive
You’re viewing 5 of 8 executive team members. Get the full list »

Moleculin Board Members (10)

Name Representing Role Since
000000000 000000 Self Board Member 000 0000
0. 000000 0000000 00.0 Self Director 000 0000
0000 0000000 00 Self Board Member 000 0000
0000000 000000 Self Board Member 000 0000
0000000 0000000 Self Director 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Moleculin Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Moleculin Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 28-Oct-2015 000000000000000000 Pharmaceuticals 000000 00000
To view Moleculin’s complete acquisitions history, request access »